27595-1-AP

antibody from Proteintech Group

Targeting: EOGT AER61, C3orf64, FLJ33770

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunoprecipitation (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

27595-1-AP

Provider

Proteintech Group

Product name

C3orf64 antibody

Antibody type

Polyclonal

Description

C3orf64 antibody (Cat. #27595-1-AP) is a rabbit polyclonal antibody that shows reactivity with Human, Mouse and has been validated for the following applications: IHC, IP, WB,ELISA.

Reactivity

Human, Mouse

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Proteome Profiling Reveals Inflammation and Fibrosis Biomarkers in Urinary Migrasomes of Patients with Diabetic Kidney Disease.

Zhou X, Guo Z, Zhang R, Yan R
Journal of proteome research 2026 May 1;25(5):2344-2358

---

Integrative bulk and single-cell transcriptomic analysis identifies a migrasome-associated lncRNA signature predictive of prognosis and immune landscape in clear cell renal cell carcinoma.

Shen J, Wang C, Zhang M, Chen B, Liu L, Tian J, Shang Z
Frontiers in immunology 2025;16:1638792

---

Urinary extracellular vesicle RNAs as novel biomarkers for diagnosis and prognosis of lupus nephritis.

Zhang H, Zheng X, Huang S, Qian L, Wu J, Shi Z, Jia M, Bai Y, Jiang L, Jia S, Zen K, Yuan Y, Liang J, Liang H
Clinical kidney journal 2025 Oct;18(10):sfaf295

---

Migrasomes derived from human umbilical cord mesenchymal stem cells: a new therapeutic agent for ovalbumin-induced asthma in mice.

Gu W, Zheng T, Li W, Luo X, Xu X, Wang Y, Mao C, Ma Y, Dong L
Stem cell research & therapy 2025 Jan 26;16(1):26

---

HSF1 Increases EOGT-Mediated Glycosylation of Notch1 to Promote IL-1β-Induced Inflammatory Injury of Chondrocytes.

Huang Y, Pan W, Bao H, Sun X, Xu C, Ma J
Cartilage 2025 Dec;16(4):486-494

---

Hypoxic migrasomes drive colorectal cancer liver metastasis by mediating CD5L(+) macrophage efferocytosis via NRP2/PROX1 axis.

Luo Y, Huang Y, Huang Y, Chen L
Journal of translational medicine 2025 Dec 8;23(1):1384

---

Quantification of urinary podocyte-derived migrasomes for the diagnosis of kidney disease.

Yang R, Zhang H, Chen S, Lou K, Zhou M, Zhang M, Lu R, Zheng C, Li L, Chen Q, Liu Z, Zen K, Yuan Y, Liang H
Journal of extracellular vesicles 2024 Jun;13(6):e12460

---

Solvent-induced proteome profiling for proteomic quantitation and target discovery of small molecular drugs.

Yu C, Chen X, Xu W, Li S, Chai Q, Zhang Y
Proteomics 2023 Jun;23(12):e2200281

---

Macrophage lineage cells-derived migrasomes activate complement-dependent blood-brain barrier damage in cerebral amyloid angiopathy mouse model.

Hu M, Li T, Ma X, Liu S, Li C, Huang Z, Lin Y, Wu R, Wang S, Lu D, Lu T, Men X, Shen S, Huang H, Liu Y, Song K, Jian B, Jiang Y, Qiu W, Liu Q, Lu Z, Cai W
Nature communications 2023 Jul 4;14(1):3945

---

Bone Marrow Mesenchymal Stem Cell-Derived Dermcidin-Containing Migrasomes enhance LC3-Associated Phagocytosis of Pulmonary Macrophages and Protect against Post-Stroke Pneumonia.

Li T, Su X, Lu P, Kang X, Hu M, Li C, Wang S, Lu D, Shen S, Huang H, Liu Y, Deng X, Cai W, Wei L, Lu Z
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2023 Aug;10(22):e2206432

---

SHCBP1 interacting with EOGT enhances O-GlcNAcylation of NOTCH1 and promotes the development of pancreatic cancer.

Yang C, Hu JF, Zhan Q, Wang ZW, Li G, Pan JJ, Huang L, Liao CY, Huang Y, Tian YF, Shen BY, Chen JZ, Wang YD, Chen S
Genomics 2021 Mar;113(2):827-842